antonio mangieri (@antoniomangieri) 's Twitter Profile
antonio mangieri

@antoniomangieri

Interventional cardiologist@ Humanitas Research Hospital, Milan, Italy

ID: 999445023396716544

calendar_today24-05-2018 00:20:37

222 Tweet

908 Followers

361 Following

Jonathan Curio (@curiojonathan) 's Twitter Profile Photo

The grand final: FILM registry on failed MV TEER by @antoniomangieri, Prof. Colombo etal. 19 centers w/4294 clips impl->3.5% clip failure 🎯67% single leaflet detach (SLD), 32% loss of insertion (LLI), 1% embolisation 🎯61% occurs intra-hospital, no correlation w/center volume

The grand final: FILM registry on failed MV TEER by @antoniomangieri, Prof. Colombo etal.

19 centers w/4294 clips impl->3.5% clip failure

🎯67% single leaflet detach (SLD), 32% loss of insertion (LLI), 1% embolisation
🎯61% occurs intra-hospital, no correlation w/center volume
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Approximately 4% of subjects >75 years have clinically relevant tricuspid regurgitation. This State-of-the-Art reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions. eurointervention.pcronline.com/article/transc…

Approximately 4% of subjects >75 years have clinically relevant tricuspid regurgitation. This State-of-the-Art reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions. eurointervention.pcronline.com/article/transc…
Jonathan Curio (@curiojonathan) 's Twitter Profile Photo

💫Top operators of the #treatTR field share complications & how to overcome them, letting the whole community learn💫 #PCRLV session moderated by Nicole Karam, MD, PhD, FESC & Fabien Praz 🧵 on 4️⃣ complications & the right solutions ⤵️ #PCRtricuspid PCRonline 🫀 Philipp Lurz antonio mangieri

PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

Good morning #CardioTwitter 👋 ! This is the last day of #PCRLV and the #PCRtricuspid group is already up and brainstorming 👩‍⚕️👨‍⚕️

Good morning #CardioTwitter 👋 ! This is the last day of #PCRLV and the #PCRtricuspid group is already up and brainstorming 👩‍⚕️👨‍⚕️
CRMjournal (@crmjournal) 's Twitter Profile Photo

Just accepted in CRMjournal! Percutaneous Suture-Based Closure of #PFO: Initial Results of a Multi-Center Experience in a Highly Selected Population by Alessandra Laricchia Francesco Giannini Antonio Colombo antonio mangieri As we await the NobleStitch EL STITCH Trial! clinicalkey.com/#!/content/pla…

Just accepted in <a href="/CRMjournal/">CRMjournal</a>!

Percutaneous Suture-Based Closure of #PFO: Initial Results of a Multi-Center Experience in a Highly Selected Population by <a href="/AleLari_MD/">Alessandra Laricchia</a> <a href="/fra_giannini1/">Francesco Giannini</a> <a href="/Antocol17/">Antonio Colombo</a> <a href="/AntonioMangieri/">antonio mangieri</a> 

As we await the NobleStitch EL STITCH Trial!

clinicalkey.com/#!/content/pla…
Journal of Invasive Cardiology (@invasivecardiol) 's Twitter Profile Photo

Mother-in-Child Assisted Tracking (MiCAT): A Mechanical Technique to Overcome Severe Radial Artery Spasm The authors present their experience using a novel MiCAT technique used to overcome severe RAS and facilitate guide catheter advancement: okt.to/DUo23x

Mother-in-Child Assisted Tracking (MiCAT): A Mechanical Technique to Overcome Severe Radial Artery Spasm

The authors present their experience using a novel MiCAT technique used to overcome severe RAS and facilitate guide catheter advancement: okt.to/DUo23x
Cardiac Interventions Today (@cardiacinterv) 's Twitter Profile Photo

Drs. Antonio Mangieri (antonio mangieri) & Antonio Colombo (Antonio Colombo) offer an overview of cutting, scoring, and very-high-pressure specialty balloons and when and how to use them in percutaneous coronary intervention (PCI). citoday.com/articles/2022-…

Andrea Scotti (@andreascotti21) 's Twitter Profile Photo

Real-world #TAVR w/ ACURATE neo2 vs Evolut PRO/PRO+: the NEOPRO-2 registry by Sara Baggio 🔎 High tech succ: NEO2 93.1% vs PRO 94.1% 🔎30-day Death 2.5%, Stroke 2.9% 🎯 PPI lower w/ NEO2 7.7% vs PRO 15.6% 🌐 eurointervention.pcronline.com/article/compar… antonio mangieri Azeem Latib EuroIntervention

Real-world #TAVR w/ ACURATE neo2 vs Evolut PRO/PRO+: the NEOPRO-2 registry by <a href="/SBaggio_/">Sara Baggio</a>

🔎 High tech succ: NEO2 93.1% vs PRO 94.1%
🔎30-day Death 2.5%, Stroke 2.9%
🎯 PPI lower w/ NEO2 7.7% vs PRO 15.6%

🌐 eurointervention.pcronline.com/article/compar…

<a href="/AntonioMangieri/">antonio mangieri</a> <a href="/azeemlatib/">Azeem Latib</a> <a href="/EuroInterventio/">EuroIntervention</a>
Alessandro Sticchi (@sticchi_alex) 's Twitter Profile Photo

Exciting step-by-step #TricValve implantation at #AictPCR 22 to treat severe #TR!! #Heterotopic valve needs a proper patient selection... Do You want know more?: jacc.org/doi/abs/10.101… PCRonline 🫀 antonio mangieri Antonio Colombo #PCRTricuspid Fabien Praz francesco maisano JACC Journals

Exciting step-by-step #TricValve implantation at #AictPCR 22 to treat severe #TR!!
#Heterotopic valve needs a proper patient selection... Do You want know more?: jacc.org/doi/abs/10.101…

<a href="/PCRonline/">PCRonline 🫀</a> <a href="/AntonioMangieri/">antonio mangieri</a> <a href="/Antocol17/">Antonio Colombo</a> 
#PCRTricuspid 
<a href="/FabienPraz/">Fabien Praz</a> <a href="/drmaisano/">francesco maisano</a> <a href="/JACCJournals/">JACC Journals</a>
Alessandro Sticchi (@sticchi_alex) 's Twitter Profile Photo

Waiting for #PCRLV, #Innovation never stops!! We perform the Italian 1st (4th worldwide) implantation of #Tripair for #TR treatment (compassionate use). Safe & fast procedure, we'll see #Spacer role in the future! Antonio Colombo antonio mangieri Damiano Regazzoli Humanitas Milano

Waiting for #PCRLV, #Innovation never stops!! 
We perform the Italian 1st (4th worldwide) implantation of #Tripair for #TR treatment (compassionate use).
Safe &amp; fast procedure, we'll see #Spacer role in the future!
<a href="/Antocol17/">Antonio Colombo</a> <a href="/AntonioMangieri/">antonio mangieri</a> <a href="/DamianoRegazzo1/">Damiano Regazzoli</a> <a href="/HumanitasMilano/">Humanitas Milano</a>
Pier Pasquale Leone (@leoneppmd) 's Twitter Profile Photo

“This proof-of-concept study is the 🥇 to test a DCB intention-to-treat strategy guided by post-PCI Pd/Pa in complex lesions located in medium- and large-size vessels.” REDUCE-STENT Registry out JACC Journals #JACCINT Antonio Colombo Azeem Latib Damiano Regazzoli antonio mangieri

“This proof-of-concept study is the 🥇 to test a DCB intention-to-treat strategy guided by post-PCI Pd/Pa in complex lesions located in medium- and large-size vessels.”

REDUCE-STENT Registry out <a href="/JACCJournals/">JACC Journals</a> #JACCINT 

<a href="/Antocol17/">Antonio Colombo</a> <a href="/azeemlatib/">Azeem Latib</a> <a href="/DamianoRegazzo1/">Damiano Regazzoli</a> <a href="/AntonioMangieri/">antonio mangieri</a>
Alessandro Sticchi (@sticchi_alex) 's Twitter Profile Photo

One of my favorite #EuroPCR session is the #Innovators Day!! This is a glimpse into the future and how you could imagine the #mitral & #tricuspid valve treatment is the hottest field!! So inspiring to see #experts comments Azeem Latib Didier Tchetche Nicolo Piazza #PCRTricuspid

One of my favorite #EuroPCR session is the #Innovators Day!!
This is a glimpse into the future and how you could imagine the #mitral &amp; #tricuspid valve treatment is the hottest field!! So inspiring to see #experts comments <a href="/azeemlatib/">Azeem Latib</a> <a href="/didier_tchetche/">Didier Tchetche</a> <a href="/nicolo_piazza/">Nicolo Piazza</a> #PCRTricuspid
Radcliffe Cardiology (@radcliffecardio) 's Twitter Profile Photo

Crack the calcium code with antonio mangieri in this on-demand presentation from Complete Revascularization 13. ow.ly/4zVu50QOtX1 This engaging presentation covers key points on current approaches to calcified lesions and crucial clinical data, the challenges posed by

Giuseppe Biondi-Zoccai (@gbiondizoccai) 's Twitter Profile Photo

Must-read multicenter observational registry courtesy of Antonio Mangieri et al, showing that both chimney stenting and BASILICA techniques effectively prevent TAVR-induced acute coronary obstruction, with comparably acceptable periprocedural and 1-year outcomes

Must-read multicenter observational registry courtesy of Antonio Mangieri et al, showing that both chimney stenting and BASILICA techniques effectively prevent TAVR-induced acute coronary obstruction, with comparably acceptable periprocedural and 1-year outcomes